| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.059 | 0.2 |